Matthew J. Bernett

Potent <i>In vitro</i> and <i>In vivo</i> Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia

Holly M. Horton, Matthew J. Bernett, Erik Pong et al. · Cancer Research · 2008 · 271 citations · Full text

Pharmacy, Immunology, Oncology +17

Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals That a Trypsin-like Kallikrein Is Expressed in the Central Nervous System

Matthew J. Bernett, Sachiko I. Blaber, Isobel A. Scarisbrick et al. · Journal of Biological Chemistry · 2002 · 202 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release

Christina L. Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong et al. · Clinical Cancer Research · 2019 · 127 citations

Life Sciences, Immunology, Oncology +17

Targeting kallikrein 6‐proteolysis attenuates CNS inflammatory disease

Sachiko I. Blaber, Bogoljub Ćirić, Geroge P. Christophi et al. · The FASEB Journal · 2004 · 96 citations

Life Sciences, Neurology, Neuroscience +16

Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody

Seung Y. Chu, Holly M. Horton, Erik Pong et al. · Journal of Allergy and Clinical Immunology · 2012 · 93 citations

Life Sciences, Biotechnology, Immunology +17